Ap. Piovezan et al., ENDOTHELINS POTENTIATE FORMALIN-INDUCED NOCICEPTION AND PAW EDEMA IN MICE, Canadian journal of physiology and pharmacology, 75(6), 1997, pp. 596-600
The present study investigates the influence of endothelin (ET) relate
d peptides (0.3-30 pmol/paw) on both phases of nociception and on edem
a induced by intraplantar injection of formalin (0.5% in 20 mu L) in t
he mouse hind paw. The first phase of nociception (0-5 min after injec
tion) was significantly potentiated by simultaneous injection of eithe
r ET-1 (10 or 30 pmol/paw) or ET-3 (10 pmol/paw), but not of the selec
tive ETB receptor agonist sarafotoxin S6c (SRTX-c; up to 30 pmol/paw).
All three peptides potentiated the second phase (10-30 min after inje
ction) of formalin-induced nociception (at 3-30, 1-30, and 10-30 pmol/
paw for ET-1, ET-3, and SRTX-c, respectively), whereas only ET-1 (10 o
r 30 pmol/paw) effectively enhanced edema caused by formalin (30 min a
fter injection). Histamine also potentiated all three responses trigge
red by formalin, but was 30- to 100-fold less potent than ET-1. Treatm
ent with the mixed ETA/ETB receptor antagonist bosentan (10 mg/kg i.p.
, 1 h beforehand) did not influence nociceptive and edematogenic respo
nses to formalin or their potentiation by histamine (3 nmol/paw), but
did inhibit the potentiations induced by ET-1 (10 pmol/paw). Thus, ET-
1 potentiates formalin-induced nociception and edema in the mouse. The
se actions are possibly mediated via ETB and ETA receptors, respective
ly, but their true identity and the mechanisms involved still remain t
o be fully elucidated.